X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-06 | LYRA | Lyra Therapeutics, Inc. | Cavalier Jason | CFO | S - Sale | $3.36 | -769 | 518,547 | 0% | -$2,587 | ||||||
2026-01-06 | LYRA | Lyra Therapeutics, Inc. | Palasis Maria | Pres, CEO | S - Sale | $3.36 | -1,702 | 1,096,733 | 0% | -$5,726 | ||||||
| D | 2026-01-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $248.46 | -4,991 | 468,313 | -1% | -$1,240,065 | |||||
| D | 2026-01-06 | MMSI | Merit Medical Systems Inc | Peterson Neil W. | COO | S - Sale+OE | $90.00 | -5,000 | 28,369 | -15% | -$450,000 | |||||
2026-01-06 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $30.10 | -2,200 | 80,752 | -3% | -$66,221 | ||||||
2026-01-02 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $310.72 | -186 | 4,506 | -4% | -$57,794 | ||||||
| M | 2026-01-02 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $7.45 | -37,226 | 5,925,276 | -1% | -$277,183 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $7.77 | -11,170 | 245,420 | -4% | -$86,743 | |||||
| M | 2026-01-02 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $7.57 | -9,660 | 1,917,109 | -1% | -$73,148 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $7.78 | -4,999 | 153,846 | -3% | -$38,890 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $7.66 | -20,543 | 599,983 | -3% | -$157,366 | |||||
2026-01-06 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $7.48 | -619 | 170,212 | 0% | -$4,630 | ||||||
2026-01-05 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $21.01 | -100,000 | 5,396,298 | -2% | -$2,101,000 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $19.62 | -3,677 | 264,467 | -1% | -$72,144 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $19.62 | -3,460 | 228,436 | -1% | -$67,896 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $19.64 | -5,229 | 180,002 | -3% | -$102,711 | ||||||
2026-01-02 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.85 | -5,139 | 72,401 | -7% | -$148,260 | ||||||
2026-01-05 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $97.68 | -5,000 | 4,502,950 | 0% | -$488,417 | ||||||
2026-01-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $29.61 | -7,800 | 82,952 | -9% | -$230,950 | ||||||
| D | 2026-01-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $29.53 | -20,000 | 42,614 | -32% | -$590,680 | |||||
2026-01-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $241.75 | -1,000 | 86,495 | -1% | -$241,750 | ||||||
2026-01-02 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $241.75 | -50 | 9,741 | -1% | -$12,088 | ||||||
2025-12-30 | MCAGU | Mountain Crest Acquisition Corp. V | Liu Suying | CEO, CFO, 10% | S - Sale | $5.00 | -200,000 | 1,865,800 | -10% | -$1,000,000 | ||||||
2025-12-30 | MCAGU | Mountain Crest Acquisition Corp. V | Mountain Crest Global Holdings LLC | 10% | S - Sale | $5.00 | -200,000 | 1,865,800 | -10% | -$1,000,000 | ||||||
2025-12-31 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +200,000 | 10,935,090 | +2% | +$12,920 | ||||||
2025-12-29 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | S - Sale | $26.69 | -10,500 | 136,633 | -7% | -$280,201 | ||||||
2025-12-29 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $26.59 | -15,000 | 409,786 | -4% | -$398,847 | ||||||
2025-12-29 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $97.66 | -5,000 | 4,507,950 | 0% | -$488,317 | ||||||
| M | 2025-12-22 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $1.59 | -10,000 | 357,692 | -3% | -$15,947 | |||||
2025-12-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, CRO, Pres Life Sciences | S - Sale | $196.08 | -74 | 16,506 | 0% | -$14,510 | ||||||
| D | 2025-12-18 | MDLN | Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. | 10% | S - Sale+OE | $28.37 | -6,088,371 | 215,303,036 | -3% | -$172,716,735 | |||||
2025-12-19 | ICU | Seastar Medical Holding Corp | Baird Jennifer A | Dir | P - Purchase | $0.24 | +4,200 | 36,200 | +13% | +$987 | ||||||
2025-12-17 | BEAT | Heartbeam, Inc. | Strome Mark E | 10% | S - Sale | $3.58 | -250,000 | 2,900,000 | -8% | -$895,000 | ||||||
2025-12-18 | MDLN | Medline Inc. | Gic Private Ltd | 10% | S - Sale | $28.37 | -10,204,351 | 118,796,825 | -8% | -$289,480,090 | ||||||
2025-12-18 | MDLN | Medline Inc. | Gic Private Ltd | 10% | P - Purchase | $29.00 | +12,586,206 | 118,796,825 | +12% | +$364,999,974 | ||||||
| D | 2025-12-18 | MDLN | Medline Inc. | Tc Group VII S1, L.L.C. | 10% | S - Sale+OE | $29.00 | -19,136,333 | 215,303,036 | -8% | -$554,953,657 | |||||
| D | 2025-12-18 | MDLN | Medline Inc. | Carlyle Mozart Coinvestment Holdings, L.P. | 10% | S - Sale+OE | $29.00 | -19,136,333 | 215,303,036 | -8% | -$554,953,657 | |||||
| D | 2025-12-18 | MDLN | Medline Inc. | Mills Andrew J. | Dir | P - Purchase | $29.00 | +2,586,206 | 2,616,861 | >999% | +$74,999,974 | |||||
| D | 2025-12-18 | MDLN | Medline Inc. | Mills Charles N. | Dir | P - Purchase | $29.00 | +2,579,310 | 2,643,315 | >999% | +$74,799,990 | |||||
2025-12-22 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $96.73 | -5,000 | 4,512,950 | 0% | -$483,672 | ||||||
2025-12-18 | STME | Stimcell Energetics Inc. | Vahabzadeh Amir | Dir, 10% | S - Sale | $0.34 | -16,667 | 4,164,566 | 0% | -$5,667 | ||||||
2025-12-18 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $20.15 | -19,600 | 231,896 | -8% | -$394,928 | ||||||
2025-12-18 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $20.15 | -18,542 | 185,231 | -9% | -$373,540 | ||||||
| M | 2025-12-17 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $3.19 | -57,146 | 0 | -100% | -$182,090 | |||||
2025-12-16 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $19.64 | -19,900 | 641,432 | -3% | -$390,836 | ||||||
2025-12-16 | ATEC | Alphatec Holdings, Inc. | Pelizzon David R | Dir | S - Sale | $19.66 | -250,000 | 10,741,872 | -2% | -$4,915,000 | ||||||
2025-12-16 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $8.31 | +13,958 | 7,111,298 | 0% | +$115,963 | ||||||
2025-12-16 | ADGM | Adagio Medical Holdings, Inc. | Kaster Deborah | CFO | P - Purchase | $1.20 | +15,000 | 15,000 | New | +$17,973 | ||||||
2025-12-17 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale | $196.03 | -629 | 13,105 | -5% | -$123,303 | ||||||
2025-12-16 | HTFL | Heartflow, Inc. | Lightcap Jeffrey C | Dir | P - Purchase | $26.34 | +40,000 | 6,737,556 | +1% | +$1,053,680 | ||||||
2025-12-15 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $96.75 | -5,000 | 4,517,950 | 0% | -$483,729 | ||||||
2025-12-15 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $45.11 | -5,000 | 193,842 | -3% | -$225,550 | ||||||
2025-12-12 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $88.85 | -4,000 | 12,419 | -24% | -$355,400 | ||||||
2025-12-15 | PODD | Insulet Corp | Frederick Wayne A.I. | Dir | S - Sale | $293.09 | -1,851 | 2,158 | -46% | -$542,510 | ||||||
2025-12-12 | ADGM | Adagio Medical Holdings, Inc. | Usen Todd | CEO | P - Purchase | $1.09 | +207,315 | 207,315 | New | +$225,973 | ||||||
2025-12-11 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $308.82 | -15,000 | 259,020 | -5% | -$4,632,292 | ||||||
| M | 2025-12-11 | SNWV | Sanuwave Health, Inc. | Manchester Management Co LLC | Director by Deputization | S - Sale | $27.95 | -20,000 | 982,632 | -2% | -$559,066 | |||||
| M | 2025-12-11 | SI | Shoulder Innovations, Inc. | Points Jeffrey S. | CFO | P - Purchase | $14.82 | +2,000 | 54,495 | +4% | +$29,632 | |||||
| M | 2025-12-11 | SI | Shoulder Innovations, Inc. | Ball Robert Joseph | CEO, Exec COB | P - Purchase | $14.86 | +7,200 | 118,457 | +6% | +$107,009 | |||||
2025-12-10 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $20.84 | -32,584 | 1,256,558 | -3% | -$679,051 | ||||||
2025-12-10 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $20.79 | -21,106 | 439,767 | -5% | -$438,794 | ||||||
2025-12-11 | ATEC | Alphatec Holdings, Inc. | Demski David M | Dir | S - Sale | $21.20 | -30,000 | 399,623 | -7% | -$636,000 | ||||||
| D | 2025-12-11 | IRMD | Iradimed Corp | Glenn John | CFO | S - Sale+OE | $97.29 | -15,000 | 8,460 | -64% | -$1,459,342 | |||||
2025-12-11 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | S - Sale | $0.36 | -4,900 | 92,544 | -5% | -$1,742 | ||||||
2025-12-10 | UFPT | Ufp Technologies Inc | Holt Jason | VP | S - Sale | $213.58 | -100 | 7,678 | -1% | -$21,358 | ||||||
2025-12-09 | ICU | Seastar Medical Holding Corp | Messinger Michael | CFO | P - Purchase | $0.35 | +14,500 | 17,500 | +483% | +$5,098 | ||||||
| D | 2025-12-09 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $107.27 | -5,000 | 34,905 | -13% | -$536,350 | |||||
2025-12-09 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.81 | +5,073 | 835,823 | +1% | +$9,182 | ||||||
| AM | 2025-12-08 | SNWV | Sanuwave Health, Inc. | Manchester Management Co LLC | Director by Deputization | S - Sale | $30.73 | -144,810 | 1,002,632 | -13% | -$4,450,061 | |||||
| D | 2025-12-08 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $19.33 | -20,000 | 120,422 | -14% | -$386,594 | |||||
| M | 2025-12-08 | SNWV | Sanuwave Health, Inc. | Manchester Management Co LLC | Director by Deputization | S - Sale | $30.73 | -144,810 | 1,002,632 | -13% | -$4,450,061 | |||||
| M | 2025-12-08 | ATEC | Alphatec Holdings, Inc. | Pelizzon David R | Dir, 10% | S - Sale | $21.18 | -250,000 | 10,991,872 | -2% | -$5,295,098 | |||||
| M | 2025-12-08 | ATEC | Alphatec Holdings, Inc. | Squadron Capital LLC | 10% | S - Sale | $21.18 | -250,000 | 10,645,045 | -2% | -$5,295,098 | |||||
2025-12-08 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $21.45 | -988 | 460,873 | 0% | -$21,193 | ||||||
| M | 2025-12-08 | ATEC | Alphatec Holdings, Inc. | Squadron Capital Holdings LLC | 10% | S - Sale | $21.18 | -250,000 | 10,645,045 | -2% | -$5,295,098 | |||||
| M | 2025-12-08 | ATEC | Alphatec Holdings, Inc. | Pritzker Jennifer N. | 10% | S - Sale | $21.18 | -250,000 | 13,465,781 | -2% | -$5,295,098 | |||||
2025-12-09 | IRMD | Iradimed Corp | Hawkins James B | Dir | S - Sale | $96.61 | -3,000 | 28,742 | -9% | -$289,838 | ||||||
2025-12-05 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $300.13 | -300 | 63,836 | 0% | -$90,039 | ||||||
2025-12-05 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $21.47 | -10,875 | 661,332 | -2% | -$233,486 | ||||||
2025-12-05 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $21.47 | -22,889 | 345,442 | -6% | -$491,526 | ||||||
2025-12-08 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | S - Sale | $1.99 | -23,321 | 93,910 | -20% | -$46,409 | ||||||
2025-12-08 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $95.43 | -5,000 | 4,522,950 | 0% | -$477,163 | ||||||
2025-12-08 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $44.42 | -4,572 | 130,058 | -3% | -$203,084 | ||||||
2025-12-02 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.07 | +100,000 | 10,735,090 | +1% | +$7,220 | ||||||
| D | 2025-12-08 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $251.41 | -4,991 | 468,313 | -1% | -$1,254,796 | |||||
2025-12-08 | SINT | Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | P - Purchase | $4.26 | +8,200 | 201,067 | +4% | +$34,896 | ||||||
2025-12-04 | BVS | Bioventus Inc. | Nohra Guy P | Dir | S - Sale | $7.57 | -10,000 | 116,610 | -8% | -$75,658 | ||||||
2025-12-05 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.86 | +5,073 | 833,113 | +1% | +$9,436 | ||||||
2025-12-05 | PODD | Insulet Corp | Stonesifer Timothy C. | Dir | P - Purchase | $311.73 | +962 | 4,591 | +27% | +$299,884 | ||||||
2025-12-05 | SINT | Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | P - Purchase | $3.93 | +65,000 | 192,867 | +51% | +$255,350 | ||||||
2025-12-04 | GUTS | Fractyl Health, Inc. | Rajagopalan Harith | CEO | P - Purchase | $1.92 | +10,416 | 1,104,725 | +1% | +$19,999 | ||||||
| D | 2025-12-03 | IVF | Invo Fertility, Inc. | Szot Matthew K | Dir | S - Sale+OE | $1.52 | -4 | 0 | -100% | -$6 | |||||
| M | 2025-12-03 | ALUR | Allurion Technologies, Inc. | Davin Michael R | Dir | S - Sale | $1.53 | -3,212 | 1,206 | -73% | -$4,918 | |||||
2025-12-04 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.85 | +10,130 | 828,040 | +1% | +$18,741 | ||||||
| D | 2025-12-03 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $45.46 | -30,921 | 800,993 | -4% | -$1,405,700 | |||||
2025-12-03 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $45.30 | -7,315 | 156,093 | -4% | -$331,370 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $29.34 | -1,063 | 90,752 | -1% | -$31,184 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $29.34 | -1,427 | 42,614 | -3% | -$41,862 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $29.34 | -3,278 | 97,924 | -3% | -$96,163 | ||||||
2025-12-02 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $139.00 | -1,200 | 27,846 | -4% | -$166,800 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |